sciencespeaks.wordpress.com
What We’re Reading | Science Speaks: HIV & TB News
https://sciencespeaks.wordpress.com/2010/09/30/what-were-reading-15
Science Speaks: HIV and TB News. A project of the Center for Global Health Policy. Laquo; 2nd Global Forum on TB Vaccines concludes, looks to the future. Hearing rebuts myths about PEPFAR’s impact. What We’re Reading. September 30, 2010 by Hannah Fishman. Ken Mayer co-chair of the Center’s Scientific Advisory Committee has a review article on the use of antiretroviral therapy (ART) as HIV prevention in this month’s issue of the American Journal of Public Health. HIV infection in Ukraine continues to spre...
sciencespeaks.wordpress.com
clubinski | Science Speaks: HIV & TB News
https://sciencespeaks.wordpress.com/author/clubinski
Science Speaks: HIV and TB News. A project of the Center for Global Health Policy. October 5, 2010. FDA awards nearly $3 million for TB research. September 3, 2010. ID research group in Zambia: We need more resources. August 19, 2010. Day two in Africa: Visiting an “academic institute and an agent for social change”. August 18, 2010. A meeting with clinicians and activists in South Africa. July 22, 2010. UNAIDS, STOP TB Partnership Commit to Half TB Deaths in PLHA by 2015. July 22, 2010. July 21, 2010.
sciencespeaks.wordpress.com
DOTS Not Enough When it Comes to TB in South Africa | Science Speaks: HIV & TB News
https://sciencespeaks.wordpress.com/2009/09/29/dots-not-enough-when-it-comes-to-tb-in-south-africa
Science Speaks: HIV and TB News. A project of the Center for Global Health Policy. Laquo; Goosby Takes on Hot Topics at State Department Session. TB, A Global Threat That Requires New Vision, Strong Leadership. DOTS Not Enough When it Comes to TB in South Africa. September 29, 2009 by dshesgreen. Why is TB control failing in South Africa? Asks Dr. Wood, a renowned physician-scientist who has been on the front lines of HIV/AIDS treatment, research and prevention for two decades and has recently done c...
hepcoalition.org
Advocate - hepCoalition
http://www.hepcoalition.org/advocate
1593;ربي. 1088;усский. Equitable access to HCV drugs. Petition to stop Gilead’s anti-diversion program that violates physician and patient rights to protect its profit. More. Doctors of the World opposes the patent on sofosbuvir. Hepatitis C: scourge, remedy and scandal. Download the full Q&A booklet. A new online crowdsourcing platform. Activist Strategies for Increasing Access to HCV Treatment in Low- and Middle-Income Countries. Dowload this report as a PDF. From the Introduction Liver disease from he...
hepcoalition.org
18th International Conference on AIDS and STIs in Africa (ICASA) - hepCoalition
http://www.hepcoalition.org/news/calendar/article/18th-international-conference-on
1593;ربي. 1088;усский. 18th International Conference on AIDS and STIs in Africa (ICASA). The 18th International Conference on AIDS and STIs in Africa will be held from November, 29th to December, 4th in Harare, Zimbabwe. The objectives of ICASA 2015 are:. Increase African leadership and ownership, as well as investment in financing to support the continental health response. Promote the development and scale up of evidence-based interventions for HIV/AIDS and associate diseases in the post 2015 era.
hepcoalition.org
Advocacy tools - hepCoalition
http://www.hepcoalition.org/advocate/advocacy-tools
1593;ربي. 1088;усский. Articles in this section. Doctors of the World opposes the patent on sofosbuvir. Hepatitis C: scourge, remedy and scandal. Download the full Q&A booklet. The patent opposition A patent opposition is a recourse by which any interested party may contest the validity of a patent at the office that issued it.It has already been used by civil society in other countries (India, Brazil, United States) to get abusive (.) More. A new online crowdsourcing platform. On September 14, 2014, Gil...
marialopezgarachana.com
curación | María López Garachana
https://marialopezgarachana.com/tag/curacion
Archivo de etiquetas curación. CURAR LAUCEMIA Y VIH AL MISMO TIEMPO. El Hospital Puerta de Hierro de Madrid, España lleva a cabo un proyecto pionero en el mundo: el primer ensayo clínico que utilizará células madre para curar el VIH en pacientes con leucemia o linfoma. Ya se han obtenido dos casos de superación de ambas enfermedades tras un trasplante de células madre de cordón umbilical. Http:/ www.elpais.com. Http:/ www.cib.csic.es. Http:/ www.leucemiaylinfoma.com/pacientes/hospitales. En un artículo d...
sciencespeaks.wordpress.com
Science Speaks: HIV & TB News | A project of the Center for Global Health Policy | Page 2
https://sciencespeaks.wordpress.com/page/2
Science Speaks: HIV and TB News. A project of the Center for Global Health Policy. Clinical research fellows educate lawmakers on value of global HIV/TB programs. September 27, 2010 by Meredith Mazzotta. Eleven current and former Fogarty International and Doris Duke clinical research fellows made their way to Capitol Hill Thursday for congressional office visits with key legislators. These experiences broaden how doctors will approach patient care and the ethos of training, said Doris Duke fellow Andrea ...
hepcoalition.org
News - hepCoalition
http://www.hepcoalition.org/news
1593;ربي. 1088;усский. Articles in this section. Civil Society Groups Tell UNITAID: Support access mechanisms led by civil society, not the pharmaceutical industry. Letters from global groups express deep concerns about the Medicines Patent Pool’s entry into hepatitis C treatment. Call to action to scale up global hepatitis response. Global partners’ meeting on hepatitis (convened by WHO in March 2014 in Geneva). Read the original document from WHO. Leadership by WHO Director Dr Margaret Chan. World Hepa...
SOCIAL ENGAGEMENT